Form 8-K MACROGENICS INC For: Dec 16
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Nasdaq, S&P dip, trading choppy as tech stocks fall
- Brent settles at lowest since before start of Iran war as more tankers exit Hormuz
- All eyes on Micron earnings tonight as sell-off raises stakes for AI memory trade
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- JPMorgan raises S&P 500 target to 7,800, says earnings revision ’unprecedented’
- Needham Starts NeoVolta (NEOV) at Buy
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- UBS Reiterates Buy Rating on Snowflake Inc. (SNOW)
MacroGenics (MGNX) PT Raised to $37 at Wedbush on MARGENZA Approval
December 17, 2020 12:40 PM ESTWedbush analyst David Nierengarten raised the price target on MacroGenics (NASDAQ: MGNX) to $37.00 (from $32.00) while maintaining an Outperform rating after MARGENZA was approved in HER2+ mBC.
... More